NCT07185880
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07185880
Title A Phase 1 Study of the Safety and Tolerability of MT-125 in GBM Patients (STAR-GBM)
Acronym STAR-GBM
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Myosin Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.